3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Hereditary Sensory and Autonomic Neuropathies
1
Breast Neoplasms
1
Interventions
Sunitinib
7
pembrolizumab
4
Nivolumab
4
cabozantinib
2
belzutifan
2
Ipilimumab
2
Everolimus
2
Axitinib
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
sacituzumab govitecan
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
lenvatinib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
avelumab
1
adavosertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Renal Cell
×
Alpelisib
×
Clear all
No trials found.